Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
15.10
+0.56 (3.85%)
At close: Jul 21, 2025, 4:00 PM
15.20
+0.10 (0.66%)
Pre-market: Jul 22, 2025, 8:56 AM EDT
Liquidia Employees
Liquidia had 170 employees as of December 31, 2024. The number of employees increased by 25 or 17.24% compared to the previous year.
Employees
170
Change (1Y)
25
Growth (1Y)
17.24%
Revenue / Employee
$83,200
Profits / Employee
-$815,753
Market Cap
1.29B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LQDA News
- 21 days ago - What Next For Liquidia After Launch? - Seeking Alpha
- 4 weeks ago - Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™ - GlobeNewsWire
- 7 weeks ago - Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD - GlobeNewsWire
- 7 weeks ago - These Analysts Boost Their Forecasts On Liquidia - Benzinga
- 7 weeks ago - Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - GlobeNewsWire
- 2 months ago - Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - GlobeNewsWire
- 2 months ago - Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript - Seeking Alpha